Have you ever wondered why some people cannot stand bitter foods like kale, broccoli, black coffee or dark chocolate, while ...

Dr. Jonathan R. Strosberg, discussed results of the CABINET trial evaluating Cabometyx versus placebo in advanced ...

CARGO Therapeutics, Inc. (CRGX – Research Report) received a Hold rating and price target from William Blair analyst Sami Corwin today. The ...

Novartis AG NVS, a Swiss pharma giant, is scheduled to report fourth-quarter 2024 and full-year results on Jan. 31, 2025. The ...

Dr. Jerome Zeldis and Dr. Blythe Sather bring exceptional backgrounds in cell therapy and solid tumorsCAMBRIDGE, Mass., Jan.

Barclays analyst Gena Wang maintained a Buy rating on Legend Biotech (LEGN – Research Report) today and set a price target of $94.00. The ...

The biotech sector in 2025 presents a landscape brimming with both opportunities and challenges. The industry is being shaped ...

Department of Oncology, Yuhuangding Hospital, Affiliated with Medical College of Qingdao University, Yantai, Shandong, China Background: Dermatomyositis is an idiopathic inflammatory myopathy and ...

The company’s marketed products include, Cometriq (cabozantinib), an inhibitor of multiple receptor tyrosine kinases; Cabometyx (cabozantinib) developed for the treatment of patients with advanced ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

They want to relinquish that role to ringfence the companies from any fallout from the PTC India inquiry. They aim to limit participation in PTC India's affairs, such as board representation, ...